Latest immunology News | Page 9

PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
ANU immunologist elected to Royal Society
T cell behavior determines immunotherapy success
Pub talks take science to people
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
Protein contributes to drug tolerance in tuberculosis
Dog coronavirus jumps to humans, with protein shift
AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts
Decreased Genetic Diversity in Immune System Could Impact Endangered Toad Survival
Findings open way for personalised MS treatment
Lupus-causing gene paves way for new and tailored treatments
Australian scientists find genetic cause of lupus
Professor Elizabeth Hartland to Chair VicAAMRI
Professor Elizabeth Hartland new Chair of VicAAMRI
Could releasing ‘handbrake’ immune cells help supercharge immunity?
Telethon grants give boost to children’s health research
First round of funded projects announced from Benkovic Research Initiative
AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia
Ludwig Cancer Research scientists to present advances in cancer immunotherapy, metastasis
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Promising nose spray could prevent and treat Covid
Darling Downs Hospital and Health Board strengthened by incoming specialists
Study reveals structure of anti-tumor therapy’s target
Four Ludwig Cancer Research scientists named Fellows of American Association for Cancer Research
Vaccine-induced T cells provide long-lasting immune response to Covid: study
Toxin-producing yeast strains in gut fuel IBD
AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomiris
Elevated inflammation persists in immune cells months after mild Covid
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Ultomiris Now Available on PBS to treat Paroxysmal Nocturnal Haemoglobinuria
Scientists identify key regulator of malaria parasite spread
12 research projects at University of Toronto and its partner hospitals receive support through John R. Evans Leaders Fund
Unexpected findings detailed in new portrait of HIV
Study finds gut fungi influence neuroimmunity, behavior
Researchers one step closer to preventing asthma in children
Gut bacteria linked to immune suppression in pancreatic cancer: Study
Versatile new pipeline enables study of gut bacteria
Benkovics support pioneering research in chemistry and life sciences
‘Boot camp’ enzyme prevents autoimmune conditions
Weapon in immune system arsenal could unlock MS treatment
What causes long COVID symptoms? Clues from under microscope
COVID variant siblings show different levels of virulence
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
Flu, measles vaccines could help flatten COVID curve
Microbe communities discovered under Antarctica’s Ross Ice Shelf
Spleen function discovery could lead to better treatments for infectious diseases
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed